ロード中...
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
Glioblastoma (GBM), the most common and malignant brain tumor, is classified according to its isocitrate dehydrogenase (IDH) mutation status in the 2016 World Health Organization (WHO) brain tumor classification scheme. The standard treatment for GBM is maximal resection, radiotherapy, and Temozolom...
保存先:
| 出版年: | Molecules |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6749405/ https://ncbi.nlm.nih.gov/pubmed/31443404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24173046 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|